FDA Gives Clearance to 2 OTC Continuous Glucose Monitoring Systems
Continuous glucose monitoring systems offer timely biofeedback for patients with type 2 diabetes.
Source: pharmacytimes.com
📰 Libre Rio News
Libre Rio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Libre Rio. Real-time updates on events, politics, business and more.
FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin
The FDA granted clearance for two new over-the-counter continuous glucose monitoring systems, one for adults with type 2 diabetes who do not use insulin and another for adults without diabetes, according to an industry press release. The FDA cleared the Abbott Libre Rio for adults aged 18 years and older with type 2 diabetes. The OTC CGM is designed for adults who do not use insulin and who
Jill Rollet El Camino Health Heart Vascular Institute Abbott Libre Rio Abbott Lingo Abbott Freestyle Libre
Source: healio.com
FDA clears 2 Abbott OTC glucose monitors
Abbott Laboratories received U.S. FDA clearance for its Lingo and Libre Rio over-the-counter continuous glucose monitoring systems, enabling it to challenge Dexcom Inc. in this rapidly growing market. Dexcom received FDA clearance for its OTC Stela continuous glucose monitor in March.
Source: bioworld.com